Log In
BCIQ
Print this Print this
 

ABT-957

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionCalpain inhibitor
Molecular Target Calpain
Mechanism of ActionCalpain inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat mild to moderate Alzheimer's disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today